Company: PSTV
Filing Date: 2025-07-21
Form Type: DEF 14A
Source: 0001140361-25-026611
Chunk: 94

Company: PLUS THERAPEUTICS, INC.
Filing Date: 2025-07-21
Form: DEF 14A
Chunk 94
---
 any such director, executive officer or nominee                    |     |                   — |
| Each other person who received, or is to receive, 5% of such awards                  |     |                   — |
| All employees, including current officers who are not executive officers, as a group |     |              87,404 |

| (1) | Greg Petersen resigned from the Board on April 18, 2025. |

Kyle Guse was elected to our Board in April 2025 and did not earn any option awards during fiscal year 2024. Required Vote The proposal to approve the fifth amendment and restatement of our 2020 Stock Incentive Plan requires the affirmative vote of a majority of the Common Stock having voting power present in person or represented by proxy at the Annual Meeting. Abstentions are considered present and entitled to vote with respect to this proposal and will, therefore, be treated as votes “against” this proposal. YOUR BOARD UNANIMOUSLY RECOMMENDS A VOTE “FOR” THE APPROVAL OF THE FIFTH AMENDMENT AND RESTATEMENT OF OUR 2020 STOCK INCENTIVE PLAN.

58

TABLE OF CONTENTS OTHER MATTERS As of the time of preparation of this Proxy Statement, neither the Board nor management intends to bring before the meeting any business other than the matters referred to in the Notice and this Proxy Statement. If any other business should be properly brought before the meeting, or any adjournment or postponement thereof, the designated proxy holders will vote on such matters according to their best judgment. Stockholders Sharing the Same Address Stockholders who hold their shares through a bank, broker or other holder of record (a “street-name stockholder”) and share a single address, may receive only one copy of the proxy materials to that address unless contrary instructions from any stockholder at that address were received. This practice, known as “householding,” is intended to reduce our printing and postage costs. However, any such street-name stockholder residing at the same address who wishes to receive a separate copy of this Proxy Statement or accompanying 2024 Annual Report may request a copy by contacting us by telephone at: (737) 255-7194. Please contact your bank, broker or other holder of record if you wish to start or stop householding of our proxy materials. Stockholder Proposals for the 2026 Meeting Deadlines Stockholders interested in submitting a proposal for consideration at our 2026 Annual Meeting of Stockholders must do so by sending such